SAB4200256
Anti-AKT1S1 antibody, Mouse monoclonal
clone AKT1S1-3, purified from hybridoma cell culture
别名:
Monoclonal Anti-AKT1 substrate 1 (proline-rich), Monoclonal Anti-Lobe, Monoclonal Anti-PRAS40, Monoclonal Anti-PROLINE-RICH AKT SUBSTRATE, 40-KD
登录查看公司和协议定价
所有图片(2)
About This Item
UNSPSC代码:
12352203
NACRES:
NA.44
推荐产品
生物来源
mouse
偶联物
unconjugated
抗体形式
purified from hybridoma cell culture
抗体产品类型
primary antibodies
克隆
AKT1S1-3, monoclonal
表单
buffered aqueous solution
分子量
antigen ~40 kDa
种属反应性
human
浓度
~1.0 mg/mL
技术
immunoprecipitation (IP): suitable
western blot: 2-8 μg/mL using whole extracts of human MDA-MB-231cells.
同位素/亚型
IgG1
UniProt登记号
运输
dry ice
储存温度
−20°C
靶向翻译后修饰
unmodified
基因信息
human ... AKT1S1(84335)
一般描述
AKT1S1 is a raptor-associated protein that interacts with mTORC1 and subsequently inhibits the mTORC1 signaling pathway. This raptor-binding protein also inhibits phosphorylation of S6K1 and cell growth. Expression of AKT1S1 has been implicated in breast and pulmonary carcinogenesis, as well as in mediating insulin sensitivity . Monoclonal Anti-AKT1S1 antibody is specific for human AKT1S1 (approx. 40 kDa).
Monoclonal Anti-AKT1S1 (mouse IgG1 isotype) is derived from the hybridoma AKT1S1-3 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a fusion protein corresponding to the N-terminus of human AKT1S1. Akt1 substrate 1 (AKT1S1) is also named as proline-rich Akt-substrate of 40 kDa (PRAS40). The rapamycin-sensitive mammalian target of rapamycin complex 1 (mTORC1) consists of mTOR, raptor, mLST8 and AKT1S1, that controls protein translation. AKT1S1 contains a TOR signaling (TOS) motif that mediates its binding to mTORC1.
免疫原
The corresponding sequence differs by a single amino acid in rat, and by 2 amino acids in mouse AKT1S1.
fusion protein corresponding to the N-terminus of human AKT1S1.
应用
Monoclonal Anti-AKT1S1 antibody is suitable for use in western blot (2-8 μg/mL using whole extracts of human MDA-MB-231cells) and immunoprecipitation.
生化/生理作用
Akt1 substrate 1 (AKT1S1) is involved in the PI3KAkt/ protein kinase B (PKB) survival pathway. Phosphorylation of AKT1S1 by Akt and mammalian target of rapamycin complex 1 (mTORC1) disrupts the binding between mTORC1 and AKT1S1, relieves the inhibitory effect of AKT1S1 on mTORC1 activity, and leads to the binding of AKT1S1 to 14-3-3, a cytosolic anchor protein. The binding of AKT1S1 to 14-3-3 requires amino acids and insulin, which is partially inhibited by rapamycin.
外形
0.01M 磷酸缓冲盐溶液，pH 7.4，含 15mM 叠氮化钠。
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
12 - Non Combustible Liquids
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
Role of PRAS40 in Akt and mTOR signaling in health and disease
Wiza C, et al.
American Journal of Physiology. Endocrinology and Metabolism, 302(12), E1453-E1460 (2012)
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding
Wang L, et al.
Test, 282(27), 20036-20044 (2007)
PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex
Fonseca BD, et al.
Test, 282(34), 24514-24524 (2007)
Emilie Vander Haar et al.
Nature cell biology, 9(3), 316-323 (2007-02-06)
Insulin stimulates protein synthesis and cell growth by activation of the protein kinases Akt (also known as protein kinase B, PKB) and mammalian target of rapamycin (mTOR). It was reported that Akt activates mTOR by phosphorylation and inhibition of tuberous
Bei Huang et al.
Acta pharmacologica Sinica, 26(10), 1253-1258 (2005-09-22)
To study the expression of proline-rich Akt-substrate PRAS40 in the cell survival pathway and tumor progression. The effects of three key kinase inhibitors on PRAS40 activity in the cell survival pathway, serum withdrawal, H(2)O(2) and overexpression of Akt were tested.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持